Advanced Viral Research CP (ADVR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Viral Research CP (ADVR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Chavez who wrote (1877)	12/14/1996 2:47:00 PM
From: .com	of 2281

Mark, thanks for posting that link to an article on picking bio-techs to invest in. However, if following the suggestions in the article ADVR is a horrible investment. Below are some of the section headings (with an ) and a sentence or 2 from each section. Avoid the one-trick pony Know who is running the show. "I'd be careful with the genius scientist who starts a company without knowing what the market is looking for," says Bin Huang, analyst with Griffiths McBurney & Partners. Don't forget the patent. Patent disputes can turn a nice story into a nightmare. Joining the A team. Be suspicious of companies that are well into clinical trials without securing a marketing or research partner, a sign that the drug's commercial prospects may be limited. Look for substantial milestone payments and cash commitments when the deal is announced, not just nebulous talk about a research alliance. Watch the piggy bank. It takes cash and lots of it to keep the Bunsen burners going. Look for companies that have a minimum of two years' cash reserves. Twelve months or less and alarm bells should be going off. (Most companies make public their monthly rate of cash burn.) Hmmmm... The stuff they say to avoid sounds familiar.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next